M Thomas1, M Jordan. 1. Abteilung für Fuß- und Sprunggelenkschirurgie, Hessingpark- Clinic, Hessingstr.17, 86199, Augsburg, Deutschland, manfred.thomas@hessingpark-clinic.de.
Abstract
BACKGROUND: Rheumatoid arthritis is found in approximately 2 % of the total population in Europe and the peak incidence of the disease is during the fourth and fifth decades of life. In approximately 15 % the first symptoms of the disease occur at the level of the foot and ankle. If the early stage-dependent therapy with pharmaceuticals fails isolated surgery of the tendons (e.g. tenosynovectomy) and reconstructive surgery including the tendons (e.g. tendon transfer and tendon readaptation) are performed to keep the patient mobile. OBJECTIVES: The aim of this article is to give an overview of the most commonly used interventions in the reconstruction of tendons in rheumatism patients and the corresponding indications. The conservative therapy options for rheumatic foot and ankle alterations with a special emphasis on tendon pathologies have a well-established importance and are also presented. METHODS: A selective literature search was carried out for therapeutic options of rheumatic tendon pathologies. DISCUSSION: If possible attempts should be made to preserve functional qualities using tenosynovectomy, tendon sutures or tendon transfer operations. If joints are already destroyed or dislocated, tendon operations should be carried out only as combined interventions with arthrodesis, endoprostheses or resection arthroplasty. The time window in which these interventions are possible should not be missed. Orthotic devices, bandages or even orthopedic shoes provide external support and splinting but do not represent a causal therapy.
BACKGROUND:Rheumatoid arthritis is found in approximately 2 % of the total population in Europe and the peak incidence of the disease is during the fourth and fifth decades of life. In approximately 15 % the first symptoms of the disease occur at the level of the foot and ankle. If the early stage-dependent therapy with pharmaceuticals fails isolated surgery of the tendons (e.g. tenosynovectomy) and reconstructive surgery including the tendons (e.g. tendon transfer and tendon readaptation) are performed to keep the patient mobile. OBJECTIVES: The aim of this article is to give an overview of the most commonly used interventions in the reconstruction of tendons in rheumatismpatients and the corresponding indications. The conservative therapy options for rheumatic foot and ankle alterations with a special emphasis on tendon pathologies have a well-established importance and are also presented. METHODS: A selective literature search was carried out for therapeutic options of rheumatic tendon pathologies. DISCUSSION: If possible attempts should be made to preserve functional qualities using tenosynovectomy, tendon sutures or tendon transfer operations. If joints are already destroyed or dislocated, tendon operations should be carried out only as combined interventions with arthrodesis, endoprostheses or resection arthroplasty. The time window in which these interventions are possible should not be missed. Orthotic devices, bandages or even orthopedic shoes provide external support and splinting but do not represent a causal therapy.
Authors: Loreto Massardo; Sherine E Gabriel; Cynthia S Crowson; W Michael O'Fallon; Eric L Matteson Journal: J Rheumatol Date: 2002-01 Impact factor: 4.666
Authors: George A W Bruyn; Ingrid Möller; Jesus Garrido; David Bong; Maria-Antonietta d'Agostino; Annamaria Iagnocco; Zunaid Karim; Lene Terslev; Nanno Swen; Peter Balint; Paul Baudoin; Dick Siewertsz van Reesema; Carlos Pineda; Richard J Wakefield; Esperanza Naredo Journal: Rheumatology (Oxford) Date: 2012-05-23 Impact factor: 7.580
Authors: Mohammed A Akhavani; Leigh Madden; Ian Buysschaert; Branavan Sivakumar; Norbert Kang; Ewa M Paleolog Journal: Arthritis Res Ther Date: 2009-05-08 Impact factor: 5.156
Authors: Henriette Baan; Wiepke K Drossaers-Bakkers; Rosemary Dubbeldam; Jaap J Buurke; Anand Nene; Martin A F J van de Laar Journal: BMC Musculoskelet Disord Date: 2007-11-06 Impact factor: 2.362